All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @gabi.brandao on Instagram · 203s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @gabi.brandao's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00In this case, you have to use a KIGZY!
  2. 0:01Because you have OPR phone,
  3. 0:03if you got an email, you will be able to send me a message with this term.
  4. 0:07If you do not make me into the interview,
  5. 0:08you also have to have a like and kick out of the video.
  6. 0:12This is one of the most interesting news in the day.
  7. 0:14I think this is the most interesting news of the week.
  8. 0:18This is one of the most interesting news news in the month.
  9. 0:21We have to have a link,
  10. 0:22a link in the video,
  11. 0:23and you can get the link in the video in the video.
  12. 0:25This is one of the most interesting news news news,
  13. 0:28Candidate is not coming to regular interviews, I have written books about it, when you do tickets to the software,
  14. 0:31I want to know what their
  15. 0:33interview will do!
  16. 0:34I want to know what their interview will do!
  17. 0:36I want to know that the interview will be on the phone,
  18. 0:39as well as what the interview will be on the phone.
  19. 0:42And the opportunity will be on the phone,
  20. 0:45and the opportunity will be on the phone,
  21. 0:46I will not know what to do.
  22. 0:48But if we do that, we will give you a clever view of your resume.
  23. 0:51I want to see the interview with my friends,
  24. 0:53with my friends, the other guys in the video.
  25. 0:55And my friends will get the check,
  26. 0:57I have 8 new days, ëlmay and ëlmayí, ëlmay in the age of 8, 1, 3, 6.
  27. 1:05The future is a new age, a new age of the age of 8, 2, 5.
  28. 1:08It is a major difference since all those people have a degree,
  29. 1:12but I think that has to be that kind of difference,
  30. 1:19but it is what happens when people think of each other.
  31. 1:26and we're still learning from the
  32. 1:28beginning of the 2019
  33. 1:302020
  34. 1:32and we are living in the
  35. 1:35world of the 19th century
  36. 1:37and we are not alone
  37. 1:38and we are in the 16th
  38. 1:40century and we are working
  39. 1:42in the 21st century
  40. 1:44and this is why we are
  41. 1:46working at the 21th century
  42. 1:48and we are learning
  43. 1:50from the 21st century
  44. 1:52and we are learning from the
  45. 1:5321th century
  46. 1:55a
  47. 2:14But if you look at the top, the same thing is, is that you should be able to get the same
  48. 2:21experience as you mentioned earlier.
  49. 2:22It's true that you can't find the same experience as you would be, but you don't need to find the same experience as you would be.
  50. 2:28So I'm going to go to the next section of the video and see if you can see the next section of the video.
  51. 2:35So I'm going to go to the next section of the video, which is a very good question.
  52. 2:40We've already moved to Germany since November twenty years,
  53. 2:43so I've already said that But anyway,
  54. 2:45when we were only a single single single,
  55. 2:48it was a lot of Connected
  56. 2:49we had to do it with such an immediate commitment
  57. 2:52and to some extent if it was to get there
  58. 2:54and to sort of make it easier for us to be able
  59. 2:56to be able to be at the same time.
  60. 2:57As I said for this time,
  61. 2:58I think that the academics that were
  62. 3:00recently not a single single single single
  63. 3:02will always be a little too crucial
  64. 3:04to the other...
  65. 3:05If there are no other teachers,
  66. 3:07there will be no other teachers,
  67. 3:08but a lot of teachers will have no external're
  68. 3:10and the best part is that it is a form.
  69. 3:13I hope you enjoy this video and that you enjoy it.
  70. 3:15I hope you enjoy it.
  71. 3:16It was really important to see you guys today.
  72. 3:18I hope you enjoy it.
  73. 3:19I hope you enjoy it and you will enjoy it.

@gabi.brandao's testosterone frequency claims, fact-checked

✨Brandão✨

Instagram creator

285.7K viewsView on Instagram

Quick answer

The video caption argues that testosterone injections spaced 15 to 20 days apart are harmful, a claim rooted in the pharmacokinetics of short-to-medium-acting testosterone esters like enanthate and cypionate, which have half-lives of approximately 7 to 8 days. For those specific esters, a 15 to 20-day interval routinely produces supratherapeutic peaks followed by subtherapeutic troughs, which can destabilize symptoms and erythrocytosis risk. The claim does not apply to long-acting testosterone undecanoate, which is clinically designed for extended intervals, so patients should clarify which formulation they are using before drawing conclusions from this type of content.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @gabi.brandao's testosterone frequency claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@gabi.brandao's testosterone frequency claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@gabi.brandao's testosterone frequency claims, fact-checked" from ✨Brandão✨. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video caption argues that testosterone injections spaced 15 to 20 days apart are harmful, a claim rooted in the pharmacokinetics of short-to-medium-acting testosterone esters like enanthate and cypionate, which have half-lives of approximately 7 to 8 days.

The reason this review is not generic is the source wording and the canonical claim label "trt por que uma dura a cada 15 20 dias a pior coisa que voc p." In this clip, the useful excerpt is: "In this case, you have to use a KIGZY!" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The Endocrine Society's 2018 male hypogonadism guidelines support weekly or twice-weekly injections for enanthate and cypionate to minimize peak-to-trough hormone variability.
People who land here are usually comparing the Testosterone claim with academia, testosterone, and bodybuilding.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video caption argues that testosterone injections spaced 15 to 20 days apart are harmful, a claim rooted in the pharmacokinetics of short-to-medium-acting testosterone esters like enanthate and cypionate, which have half-lives of approximately 7 to 8 days.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video caption argues that testosterone injections spaced 15 to 20 days apart are harmful, a claim rooted in the pharmacokinetics of short-to-medium-acting testosterone esters like enanthate and cypionate, which have half-lives of approximately 7 to 8 days. For those specific esters, a 15 to 20-day interval routinely produces supratherapeutic peaks followed by subtherapeutic troughs, which can destabilize symptoms and erythrocytosis risk. The claim does not apply to long-acting testosterone undecanoate, which is clinically designed for extended intervals, so patients should clarify which formulation they are using before drawing conclusions from this type of content.
  • Testosterone enanthate and cypionate have half-lives of 7 to 8 days, meaning a 15 to 20-day injection interval will produce subrtherapeutic troughs in many patients before the next dose.
  • The Endocrine Society's 2018 male hypogonadism guidelines support weekly or twice-weekly injections for enanthate and cypionate to minimize peak-to-trough hormone variability.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone enanthate and cypionate have half-lives of 7 to 8 days, meaning a 15 to 20-day injection interval will produce subrtherapeutic troughs in many patients before the next dose.
  • The Endocrine Society's 2018 male hypogonadism guidelines support weekly or twice-weekly injections for enanthate and cypionate to minimize peak-to-trough hormone variability.
  • Testosterone undecanoate injections are designed for 10-week intervals and are a legitimate exception to short-interval dosing rules, which this type of social media content rarely acknowledges.
  • Rastrelli et al. (2018, Andrology) found that symptomatic variability between injections is directly tied to pharmacokinetic fluctuation, validating the general concern about infrequent dosing with short-acting esters.
  • If you feel an energy or mood crash before your next injection, that symptom pattern is a real clinical signal worth discussing with a provider, not just an identity of TRT.
  • Injection frequency changes require serum testosterone monitoring, ideally measuring both peak and trough levels, to confirm whether an adjustment is actually improving stability.
  • No social media creator can set an appropriate injection schedule for you. Individual metabolism, ester type, dose, and lab results all determine the right interval.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @gabi.brandao actually say?

Straightforwardly: we cannot tell. The transcript available for this video is garbled beyond comprehension. What appears in the caption, "why an injection every 15 to 20 days is the worst thing you can do," is the actual claim being made. The transcript itself is a machine-translation disaster that references interviews, resumes, and 19th-century Europe, none of which have anything to do with testosterone replacement therapy. We are working from the caption claim, the hashtags, and the standard argument that circulates in Brazilian bodybuilding communities about injection frequency. That argument is well-known: long injection intervals with testosterone cause peaks and troughs that produce symptoms. The caption frames this as settled fact. It is not quite that simple, but it is not entirely wrong either. We will treat the claim at face value, because the caption makes the core assertion plainly enough.

Does the science back this up?

Partly, yes. Injection interval genuinely matters for hormone stability, but "worst thing you can do" is hyperbole that ignores clinical context. Testosterone enanthate and cypionate have half-lives of roughly 7 to 8 days, which means a 15 to 20-day injection interval does produce a significant trough by the time the next dose arrives. Testosterone levels can fall below physiological range in many patients before day 15, which produces the classic "roller coaster" symptom pattern: energy, libido, and mood improve post-injection, then decline sharply before the next dose. Rastrelli et al. (2018, Andrology) documented that symptom variability between injections is a real clinical problem tied directly to pharmacokinetic fluctuation. A systematic review by Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) established that weekly or twice-weekly injections of shorter-acting esters maintain more stable serum levels than biweekly or monthly regimens. However, some patients do maintain adequate trough levels beyond 14 days, depending on their metabolism, dose, and ester used. Blanket statements about every patient are always going to miss someone.

What did they get wrong (or right)?

The underlying pharmacology is right. Injecting testosterone enanthate or cypionate every 15 to 20 days is generally poor practice for symptom management in TRT. That part checks out. Where the claim oversimplifies is in framing a 15 to 20-day interval as universally catastrophic. Long-acting injectable testosterone undecanoate, marketed as Nebido or Aveed, is specifically designed for 10 to 14-week intervals and is approved by regulatory agencies in multiple countries for hypogonadism. Rohayem et al. (2017, Andrologia) showed that testosterone undecanoate produces acceptable stability in many patients at those intervals. So the claim, applied without specifying which ester is being discussed, is misleading. For cypionate or enanthate, the argument is solid. Stated as a universal rule for all injectable testosterone, it is inaccurate. The bodybuilding community often conflates ester types when making sweeping injection frequency recommendations, and this appears to be an example of that pattern.

What should you actually know?

Injection frequency should be matched to the specific ester's half-life and your individual pharmacokinetics, confirmed through bloodwork, not a social media rule of thumb. For testosterone enanthate and cypionate, most clinical guidelines and endocrinologists now recommend weekly or twice-weekly injections to maintain stable serum levels. The Endocrine Society's 2018 clinical practice guidelines on male hypogonadism support frequent dosing schedules for short-to-medium-acting esters specifically to minimize peak-to-trough variability. If you are on a 15 to 20-day injection schedule and feeling symptomatic in the days before your next injection, that symptom pattern is real and worth discussing with a prescribing clinician. Adjusting frequency is a clinical decision that requires monitoring serum testosterone, hematocrit, and other labs. Nobody on Instagram, including this creator, should be setting your injection schedule. A regulated telehealth provider can order labs, review your pharmacokinetics, and adjust your protocol based on data rather than a video caption.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

✨Brandão✨ · Instagram creator

285.7K views on this video

POR QUE UMA DURA A CADA 15/20 DIAS É A PIOR COISA QUE VOCÊ PODE FAZER? . . . . . . #academia #testosterone #bodybuilding #hormones #ganhodemassamuscular

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about testosterone enanthate?

Testosterone enanthate and cypionate have half-lives of 7 to 8 days, meaning a 15 to 20-day injection interval will produce subrtherapeutic troughs in many patients before the next dose.

What does the video say about the endocrine society's 2018 male hypogonadism guidelines support weekly?

The Endocrine Society's 2018 male hypogonadism guidelines support weekly or twice-weekly injections for enanthate and cypionate to minimize peak-to-trough hormone variability.

What does the video say about testosterone undecanoate injections?

Testosterone undecanoate injections are designed for 10-week intervals and are a legitimate exception to short-interval dosing rules, which this type of social media content rarely acknowledges.

What does the video say about rastrelli et al. (2018, andrology) found?

Rastrelli et al. (2018, Andrology) found that symptomatic variability between injections is directly tied to pharmacokinetic fluctuation, validating the general concern about infrequent dosing with short-acting esters.

What does the video say about if you feel an energy?

If you feel an energy or mood crash before your next injection, that symptom pattern is a real clinical signal worth discussing with a provider, not just an identity of TRT.

What does the video say about injection frequency changes require serum testosterone monitoring, ideally measuring both?

Injection frequency changes require serum testosterone monitoring, ideally measuring both peak and trough levels, to confirm whether an adjustment is actually improving stability.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by ✨Brandão✨, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.